Evaluation of lapatinib as a component of neoadjuvant therapy for HER2+operable breast cancer: 5-year outcomes of NSABP protocol B-41.

被引：17

作者：

Robidoux, Andre

Tang, Gong

Rastogi, Priya

Geyer, Charles E.

Azar, Catherine A.

Atkins, James Norman

Fehrenbacher, Louis

Bear, Harry Douglas

Baez-Diaz, Luis

Sarwar, Shakir

Margolese, Richard G.

Farrar, William Blair

Brufsky, Adam M.

Shibata, Henry R.

Bandos, Hanna

Paik, Soonmyung

Costantino, Joseph P.

Swain, Sandra M.

Mamounas, Eleftherios P.

Wolmark, Norman

机构：

[1] NSABP NRG Oncol, Montreal, PQ, Canada

[2] Ctr Hosp Univ Montreal, Montreal, PQ, Canada

[3] NRG Oncol, Pittsburgh, PA USA

[4] Univ Pittsburgh, Pittsburgh, PA USA

[5] NSABP NRG Oncol, Pittsburgh, PA USA

[6] Univ Pittsburgh Med Canc Ctr, Magee Womens Hosp, Pittsburgh, PA USA

[7] Virginia Commonwealth Univ, Massey Canc Ctr, Pittsburgh, PA USA

[8] NSABP NRG Oncol, Green Valley, AZ USA

[9] Kaiser Permanente, Green Valley, AZ USA

[10] NSABP NRG Oncol, Goldsboro, NC USA

[11] Southeastern Med Oncol Ctr, Goldsboro, NC USA

[12] NSABP NRG Oncol, Novato, CA USA

[13] Kaiser Permanente Northern Calif, Novato, CA USA

[14] NRG Oncol, Richmond, VA USA

[15] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA

[16] NSABP NRG Oncol, San Juan, PR USA

[17] San Juan CCOP, San Juan, PR USA

[18] NSABP NRG Oncol, Columbus, OH USA

[19] Columbus NCORP Grant Med Ctr, Columbus, OH USA

[20] McGill Univ, Jewish Gen Hosp, Montreal, PQ, Canada

[21] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA

[22] UPMC, Magee Womens Hosp, Pittsburgh, PA USA

[23] McGill Univ Hlth Ctr, Royal Victoria Hosp, Montreal, PQ, Canada

[24] Severance BioMed Sci Inst, Pittsburgh, PA USA

[25] Yonsei Univ, Coll Med, Pittsburgh, PA USA

[26] NSABP NRG Oncol, Washington, DC USA

[27] MedStar Washington Hosp Ctr, Washington Canc Inst, Washington, DC USA

[28] NSABP NRG Oncol, Orlando, FL USA

[29] Orlando Hlth, UF Canc Ctr, Orlando, FL USA

[30] Allegheny Gen Hosp, Allegheny Canc Ctr, Pittsburgh, PA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.501

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

501

引用

页数：2

共 36 条

[1] Evaluation of lapatinib as a component of neoadjuvant therapy for HER2+operable breast cancer: NSABP protocol B-41
Robidoux, Andre
Tang, Gong
Rastogi, Priya
Geyer, Charles E.
Azar, Catherine A.
Atkins, James Norman
Fehrenbacher, Louis
Bear, Harry Douglas
Baez-Diaz, Luis
Kuebler, J. Phillip
Margolese, Richard G.
Farrar, William Blair
Brufsky, Adam
Shibata, Henry R.
Bandos, Hanna
Paik, Soonmyung
Costantino, Joseph P.
Swain, Sandra M.
Mamounas, Eleftherios P.
Wolmark, Norman
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[2] Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial
Robidoux, Andre
Tang, Gong
Rastogi, Priya
Geyer, Charles E., Jr.
Azar, Catherine A.
Atkins, James N.
Fehrenbacher, Louis
Bear, Harry D.
Baez-Diaz, Louis
Sarwar, Shakir
Margolese, Richard G.
Farrar, William B.
Brufsky, Adam M.
Shibata, Henry R.
Bandos, Hanna
Paik, Soonmyung
Costantino, Joseph P.
Swain, Sandra M.
Mamounas, Eleftherios P.
Wolmark, Norman
LANCET ONCOLOGY, 2013, 14 (12): : 1183 - 1192
[3] AERIO News in Brief Lapatinib as a Component of Neoadjuvant Therapy for HER2-positive Operable Breast Cancer (NSABP protocol B-41): an Open-Label, Randomised Phase 3 Trial
Cochereau, D.
Espie, M.
ONCOLOGIE, 2014, 16 (01) : 69 - 70
[4] DISEASE-FREE SURVIVAL ACCORDING TO PATHOLOGIC RESPONSE AND P95-HER2 IN THE CHER-LOB NEOADJUVANT STUDY OF CHEMOTHERAPY PLUS TRASTUZUMAB, LAPATINIB OR COMBINED TRASTUZUMAB AND LAPATINIB IN HER2+OPERABLE BREAST CANCER
Guarneri, V.
Bisagni, G.
Bottini, A.
Cagossi, K.
Frassoldati, A.
Piacentini, F.
Holford, C.
Bruey, J.
D'Amico, R.
Conte, P. F.
ANNALS OF ONCOLOGY, 2012, 23 : 101 - 101
[5] Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41
Priya Rastogi
Gong Tang
Saima Hassan
Charles E. Geyer
Catherine A. Azar
Gustav C. Magrinat
J. Marie Suga
Harry D. Bear
Luis Baez-Diaz
Shakir Sarwar
Jean-Francois Boileau
Adam M. Brufsky
Henry R. Shibata
Hanna Bandos
Soonmyung Paik
Greg Yothers
Sandra M. Swain
Eleftherios P. Mamounas
Norman Wolmark
Breast Cancer Research and Treatment, 2023, 199 : 243 - 252
[6] Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41
Rastogi, Priya
Tang, Gong
Hassan, Saima
Geyer Jr, Charles E.
Azar, Catherine A.
Magrinat, Gustav C.
Suga, J. Marie
Bear, Harry D.
Baez-Diaz, Luis
Sarwar, Shakir
Boileau, Jean-Francois
Brufsky, Adam M.
Shibata, Henry R.
Bandos, Hanna
Paik, Soonmyung
Yothers, Greg
Swain, Sandra M.
Mamounas, Eleftherios P.
Wolmark, Norman
BREAST CANCER RESEARCH AND TREATMENT, 2023, 199 (02) : 243 - 252
[7] Association between stromal tumor-infiltrating lymphocytes (TILs) and pathologic complete response (pCR) in patients with early breast cancer (BC) treated with neoadjuvant chemotherapy and HER2-directed therapies in NSABP B-41.
Schlam, Ilana
Tang, Gong
Harris, Brent T.
Rastogi, Priya
Wolmark, Norman
Salgado, Roberto
Swain, Sandra M.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[8] Intrinsic subtypes of HER2-positive breast cancer and their associations with pathologic complete response (pCR) and outcomes: Findings from NSABP B-41, a randomized neoadjuvant trial
Swain, Sandra M.
Tang, Gong
Lucas, Peter C.
Robidoux, Andre
Goerlitz, David
Harris, Brent T.
Bandos, Hanna
Geyer, Charles E.
Rastogi, Priya
Mamounas, Eleftherios P.
Wolmark, Norman
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[9] Surgical treatment outcomes and prognosis in HER2+invasive breast cancer patients with a DCIS component treated with neoadjuvant systemic therapy
Ploumen, R.
Claassens, E. L.
Kooreman, L. F. S.
Keymeulen, K. B. M. I.
van Kats, M. A. C. E.
van Kuijk, S. M. J.
Siesling, S.
van Nijnatten, T. J. A.
Smidt, M. L.
EUROPEAN JOURNAL OF CANCER, 2024, 200 : 30 - 30
[10] Clinical outcomes with neoadjuvant chemotherapy plus dual anti-HER2 therapy in patients with operable/locally advanced breast cancer: Single institution experience
Shah, Nirja
Shah, Nikita
Baidas, Said
Cuesta-Fernandez, Ana
Demers, Marc
Demori, Maria
Dvorak, Tomas
Eisenberg, Rachel
Gross, Terrence
Henry, Danielle
Kahky, Michael
Kelly, Patrick
Kolli, Swathy
Rostorfer, Regan
Smith, Jeffrey
Swanick, Cameron
Mamounas, Eleftherios
CANCER RESEARCH, 2021, 81 (04)

← 1 2 3 4 →